m6A Reader YTHDF1‐Targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy via Epigenetic and Immune Regulation (Adv. Mater. 8/2023)

Qing You,Fang Wang,Rong Du,Jingnan Pi,Huayi Wang,Yue Huo,Jingyi Liu,Chen Wang,Jia Yu,Yanlian Yang,Ling Zhu
DOI: https://doi.org/10.1002/adma.202370054
IF: 29.4
2023-02-26
Advanced Materials
Abstract:Engineered Extracellular Vesicles In article number 2204910, Jia Yu, Yanlian Yang, Ling Zhu, and co‐workers report an extracellular‐vesicle‐based nanodrug for the targeting delivery of short interfering RNA (siRNA) against N6‐methyladenosine (m6A) reader YTH N6‐methyladenosine RNA binding protein 1 (YTHDF1) for the epigenetic and immune regulation of gastric cancer. This versatile nanoplatform provides an efficient and low toxic strategy to inhibit epigenetic regulators and holds great potential in promoting immunotherapy.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
What problem does this paper attempt to address?